Please assess the completion status of the following clinical trial:

Trial Title: DETERMINATION OF THE CELL OF ORIGIN (COO) in LDCGB

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients diagnosed with LDCGB in the Spanish GELTAMO sites, without previous treatment and who decide to join the program.~* Age over or equal to 18 years old.~* Having voluntarily given informed consent for the sending and processing of biological samples, as well as for the analysis and reporting of the LDCGB COO results~Exclusion Criteria:~* Absence of histological material available to review histology and determine COO~* Patients with LDCGB from any other low-grade lymphoma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).